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Background/Purpose: Most severity scores can predict severe community acquired pneumonia (CAP) and
its associated poor outcomes. The impact of baseline functional status on the prediction of the outcome of
CAP remains controversial. Therefore, we aimed to detect the diagnostic accuracy of the baseline function
using activities of daily living (ADL) in prediction of mechanical ventilation (MV) and 30-daymortality and
to compare its diagnostic accuracy with the CURB-65 and SCAP scores in patients with CAP.
Methods: A prospective cohort study was conducted on 65 patients aged 60 years presenting with CAP
and admitted consecutively to geriatric and chest intensive care units in Ain Shams University Hospitals
from October 2011 to June 2012. Patients were subjected to assessment of the severity of CAP using the
CURB-65 and SCAP scores, and for baseline function using the ADL score. Follow-up for MV and 30-day
mortality was also done.
Results: The mean age of the patients was 69.9  11.4 years; 40% of patients died, 41.5% were on MV, and
75.4% had ADL score  3 points. By logistic regression, the ADL score was found to be an independent
predictor for mortality and MV in patients with CAP after adjusting for confounding factors. Using ADL
score for prediction of mortality and MV was best at cut off  3, which revealed area under the curve
(AUC) ¼ 0.705, 0.679; p ¼ 0.005, 0.015; sensitivity ¼ 100%, 96.3%; speciﬁcity ¼ 41% and 39.5%, respec-
tively. Pairwise comparison between AUCs of the ADL score and other scores revealed no signiﬁcant
difference.
Conclusion: The ADL score can be an attractive alternative to conventional indices as it is an independent
predictor for mortality and MV in patients with CAP.
Copyright  2013, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC.
 
Open access under CC BY-NC-ND license.1. Introduction
Many severity scores are considered useful tools that help cli-
nicians to predict the outcome of patients presenting with
community acquired pneumonia (CAP).1,2 Most of them can predict
severe CAP and its associated poor outcomes.3,4 There is no uni-
versally accepted deﬁnition for severe CAP, but in the literature
severe CAP usually describes patients admitted to the intensive care
unit (ICU) with CAP.5,6ogy Department, Faculty of
t.
wafaager@med.asu.edu.eg
linical Gerontology & Geriatrics. PThe impact of baseline functional status on the prediction of the
outcome of pneumonia remains controversial.7e9 Several studies
have reported a signiﬁcant association between dependency and
short-term mortality in elderly patients suffering from pneu-
monia,7,8 while some studies have not reported this association.9
This unresolved issue presents a problem in clinical practice
because pneumonia is a common and serious illness and the
leading infectious cause of mortality, especially in the elderly
population.10 In addition, functional decline is one of the most
prevalent clinical syndromes in the elderly people and approxi-
mately 40% of them have some degree of disability.11
Immobile elderly patients have diminished delayed hypersen-
sitivity response to tuberculin, an important marker of T helper-1
function, which can exaggerate the risk of pneumonia-related
mortality.12 At the same time, it is found that improving theublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Table 1
General description of personal and clinical characteristics, pneumonia severity
scores, and ADL score in patients with CAP.
Variable Pneumonia (n ¼ 65)
Age 69.9  11.4
Sex (male) 60% (n ¼ 42)
LOS 11.4  7.5
Patient died 40% (n ¼ 26)
Patient on MV 41.5% (n ¼ 27)
CURB-65 score
First degree (1 point) 33.8% (n ¼ 22)
Second degree (2 points) 38.5% (n ¼ 25)
Third degree (3 points) 27.7% (n ¼ 18)
Positive SCAP 46.2% (n ¼ 30)
ADL  3 75.4% (n ¼ 49)
ADL ¼ activities of daily living; CAP ¼ community-acquired pneumonia;
LOS ¼ length of stay; MV ¼ mechanical ventilation.
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exercises can improve the immune function.14
Therefore, we directed to test the ability of ADL score to predict
worse outcomes in patients with CAP earlier than other indices
either before the occurrence of CAP, which could play an important
role in prevention, or after CAP has already occurred, which could
help in classifying patients according to the expected outcomes
(prognosis) especially in the emergency department.
Therefore, a prospective cohort study was conducted. The aim of
the study was ﬁrst to detect the diagnostic accuracy of baseline
functional status using the ADL score13 for prediction of pneumonia
outcomes in ICU [mechanical ventilation (MV) and 30-day mor-
tality], and second, to evaluate the diagnostic accuracy of the CURB-
653 and SCAP4 scores for prediction of these outcomes and
comparing their performance with the ADL score (as an indepen-
dent score).
2. Methods
2.1. Study protocol
A prospective cohort study was conducted on 65 patients aged
60 presenting with CAP and admitted consecutively to geriatric
and chest ICUs in Ain Shams University Hospitals from October
2011 to June 2012. The study had been approved by the Ethical
Committees of Geriatrics and Gerontology Department (Ain Shams
University Hospital). Informed consent was obtained from all pa-
tients or next kin.
For the purpose of this study, the diagnosis of pneumonia was
based on the Institute for Clinical Systems Improvement Health
Care Guideline for CAP diagnosis in adults,15 in which patients
present with two or more of the following complaints of lower
respiratory tract infection: rigors, pleuritic chest pain, shortness of
breath, chest tightness, deep cough, sputum production, fever over
37.8C lasting more than 72 hours, night sweats, and wheezing. In
addition, the following signs are also considered while diagnosing
the patients: temperature > 37.8C, pulse > 100 beats/minute,
decreased breath sounds, rales, or respiratory rate > 20 breath/
minute. A chest X-ray was obtained and pneumonia was conﬁrmed
if the chest X-ray showed inﬁltration of the lungs.15 Patients’
admission to the ICUwas based on OSF Saint Francis Medical Center
Critical Care admission criteria.16
Patients were excluded if they had hospital-, nursing home-, or
ventilator-acquired pneumonia, severe immunosuppression,1 or
were hospitalized within the previous 4 weeks,17 had antibiotics
within the previous 2 weeks,18 or if there were any missing data.
2.2. Data collection
Data were collected on clinical features as well as on laboratory
and radiological results available since presentation. Data on
baseline functional status 1 month before patient hospitalization
were collected upon admission using the ADL scores, which
describe the ability of the patient to perform basic self-care tasks
before illness (e.g., bathing, dressing, toileting, transferring, conti-
nence, and feeding). The ADL scores range from 0 to 6. The lower
the score, the worse the function. If patients are independent, they
scored 1 and if they are dependent, they scored 0.13 The ADL scores
were provided by both patients and caregivers.
Assessment of the severity of pneumoniawas done based on the
CURB-65 and SCAP scores. The CURB-65 score is derived from the
original British Thoracic Society study for prediction of mortality
and uses ﬁve core clinical features, namely, new onset confusion,
serum urea > 7 mmol/L, respiratory rate > 30/minute, blood
pressure (systolic blood pressure < 90 mmHg or diastolic bloodpressure < 60 mmHg), and age > 65 years.3 The presence of three
or more of these ﬁve criteria led to a “severe” classiﬁcation.3,19
The SCAP score contains eight items, two major and six minor.
At least one major criterion or two minor criteria deﬁne severe CAP
and the need for intermediate care or intensive unit care.42.3. Outcomes
Pneumonia-related outcomes were MV and 30-day mortality. A
follow-up visit was done 30 days after each patient’s entry into the
study to assess mortality.2.4. Statistical analysis
All data manipulation and analysis were performed using SPSS
version 16 (SPSS Inc., Chicago, IL, USA). Qualitative data were pre-
sented in the form of frequency tables (number and percentage).
Quantitative data were presented in the form of means and stan-
dard deviation. Descriptive statistics (frequencies and means) were
used to describe sample demographics, comorbidities, clinical data,
radiological ﬁndings, and laboratory data for the pneumonia
cohort. A p value < 0.05 was taken to be signiﬁcant.
While comparing between two groups, two-sample t test or
ManneWhitney test was used for quantitative data, and the Chi-
square test or Fisher’s exact test was used for qualitative data.
Receiver operator curve (ROC) analysis was used to ﬁnd the best
cut-off scores of ADL with best sensitivity, speciﬁcity, positive
predictive value (PPV), and negative predictive value (NPV) while
predicting mortality and MV. In addition, ROC was also used to
evaluate the performance of the CURB-653 and SCAP4 scores for
predicting these outcomes. MedCalc 9.6.2.0 package (MedCalc
Software, Mariakerke, East-Flanders, Belgium) was used to
compare between area under the curve (AUC) of ADL at the best
cut-off score and AUC of severe CURB-65 (3 points), and positive
SCAP scores for the prediction of mortality and MV. The ADL score
was tested in logistic regression models for predicting mortality
and MV after adjusting for possible confounding factors.3. Results
Sixty-ﬁve consecutive patients (mean age: 69.9  11.4 years)
participated in this study. Of these patients, 60% (n ¼ 42) were
male; 40% died (n ¼ 26) and 41.5% (n ¼ 27) were on MV. A total of
27.7% (n ¼ 18) had severe CURB-65 (3 points), 46.2% (n ¼ 30) had
positive SCAP scores, and 75.4% (n ¼ 49) had severe impairment of
ADL with score  3 points (Table 1).
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CURB-65, and SCAP scores (p < 0.001, p < 0.001, p < 0.001, and
p ¼ 0.011, respectively). In addition, MV was also signiﬁcantly
associated with worse ADL, CURB-65, and SCAP scores (p < 0.001,
p < 0.001, and p < 0.001, respectively) (Table 2).
A lower ADL score was signiﬁcantly associated with higher age,
male sex, chronic obstructive pulmonary disease, aspiration,
disturbed mental state, higher respiratory rate, worse CURB-65,
and SCAP scores (p ¼ 0.007, p ¼ 0.010, p ¼ 0.008, p ¼ 0.027,
p< 0.001, p¼ 0.001, p¼ 0.003, and p¼ 0.050, respectively; Table 3).
With logistic regression, ADL score was the only signiﬁcant pre-
dictor ofmortalityandMVafter adjustment for age, sex, and ischemic
heart disease (p ¼ 0.007 and p ¼ 0.006, respectively; Table 4).Table 2
Description of patients’ characteristics with regard to mortality end point and mechanic
Variable Mortality
No (n ¼ 39) Yes (n ¼ 26)
Agea 65 72
Sex (male) 26 (66.7%) 13 (50%)
Comorbidities
ISHD 6 (15.4%) 10 (38.5%)
CHF 10 (25.6%) 3 (11.5%)
COPD 21 (53.8%) 9 (34.6%)
CVS 3 (7.7%) 5 (19.2%)
DM 9 (23.1%) 10 (38.5%)
HTN 10 (25.6%) 10 (38.5)
Dementia 4 (10.3%) 4 (15.4%)
CKD 17 (43.6%) 14 (53.8%)
CLD 4 (10.3%) 3 (11.5%)
Clinical data
Disturbed mental state 13 (33.3%) 21 (80.8%)
Aspiration 2 (5.1%) 11 (42.3%)
Temperaturea 38 38
RRa 22 25
Pulsea 100 100
SBP 122.6 (17.3) 121.2 (24.2)
DBPa 80 80
Laboratory data
WBCsa 11 13.75
Lymphocytesa 1.4 1.25
TP 6.3 (0.9) 6.2 (0.99)
ALB 3.21 (0.78) 2.80 (0.67)
ABG
PO2 60.2 (18.4) 65.98 (16.99)
Oxygen saturationa 91 90.5
Radiological ﬁnding
Bronchopneumonia 12 (30.8%) 17 (65.4%)
Pleural effusion 10 (25.6%) 5 (19.2%)
Outcome
Mortality d d
MV 6 (22.2%) 21 (77.8%)
LOSa 9 10
ADL score
Total ADL scorea 2 0
Dependent feeding 18 (46.2%) 24 (92.3%)
Dependent bathing 23 (59%) 26 (100%)
Dependent dressing 26 (66.7%) 26 (100%)
Dependent continence 14 (35.9%) 23 (88.5%)
Dependent transfer 22 (56.4%) 25 (96.2%)
Dependent toileting 22 (56.4%) 24 (92.3%)
Pneumonia scores
CURB-65a 1 2.5
Positive SCAP 13 (33.3%) 17 (65.4%)
ABG ¼ arterial blood gases; ADL ¼ activities of daily living; ALB ¼ albumin; CHF ¼ con
COPD ¼ chronic obstructive pulmonary disease; CVS ¼ cerebrovascular stroke; DBP ¼
ISHD ¼ ischemic heart disease; LOS ¼ length of stay; MV ¼ mechanical ventilation; RR ¼
blood cells.
a ManneWhitney test was used; median is expressed in the data.
b Fisher’s exact was used.Using ROC, ADL score showed moderate diagnostic accuracy in
predicting mortality (AUC ¼ 0.705, p ¼ 0.005, sensitivity ¼ 100%,
speciﬁcity ¼ 41%, PPV ¼ 53%, and NPV ¼ 100%) and MV
(AUC ¼ 0.679, p ¼ 0.015, sensitivity ¼ 96.3%, speciﬁcity ¼ 39.5%,
PPV ¼ 53.1%, NPV ¼ 93.8%), and it was best at cut-off scores  3. In
addition, worse CURB-65 and positive SCAP scores showed mod-
erate accuracy in predicting both mortality (AUC ¼ 0.686, 0.660;
sensitivity ¼ 50%, 65.4%; NPV ¼ 72.3%, 74.3%, respectively) and MV
(AUC ¼ 0.643, 0.770; sensitivity ¼ 44.44%, 77.70%; NPV ¼ 68.09%,
82.86%, respectively; Table 5).
Pairwise comparison between AUC of ROCs of CURB and SCAP
scores with ADL (at cut-off scores  3 points) revealed no signiﬁ-
cant difference in the prediction of mortality and MV.al ventilation.
Mechanical ventilation
p No (n ¼ 38) Yes (n ¼ 27) p
0.049 65 73 0.038
0.180 27 (71.1%) 12 (44.4%) 0.031
0.030 7 (18.4%) 9 (33.3%) 0.170
0.160 9 (23.7%) 4 (14.8%) 0.380
0.130 20 (52.6%) 10 (37%) 0.201
0.260b 3 (7.7%) 5 (18.5%) 0.224
0.181 9 (23.7%) 10 (37%) 0.243
0.273 11 (28.9%) 9 (33.3%) 0.731
0.710b 4 (10.5%) 4 (14.8%) 0.634
0.421 16 (42.1%) 15 (55.6%) 0.290
0.921b 3 (7.9%) 4 (14.8%) 0.382
<0.001 14 (36.8%) 20 (74.1%) 0.003
<0.001 2 (5.3%) 11 (40.7%) <0.001
0.033 38 38 0.921
0.083 20 28 0.002
0.806 100 100 0.963
0.791 122.56 (17.2) 121.2 (24.2) 0.782
0.190 80 80 0.161
0.272 10.85 14.5 0.124
0.943 1.05 14.5 0.264
0.634 6.39 (0.9) 6.2 (0.9) 0.443
0.040 3.21 (0.7) 2.8 (0.7) 0.571
0.204 60.26 (18.4) 65.98 (16.9) 0.432
0.651 92 90 0.151
0.006 12 (31.6%) 17 (63%) 0.012
0.551 8 (21.1%) 7 (25.9%) 0.651
d 5 (13.2%) 21 (77.8%) <0.001
<0.001 d d d
0.590 8 11 0.181
<0.001 2 0 <0.001
<0.001 17 (44.7%) 25 (92.6%) <0.001
<0.001 22 (57.9%) 27 (100%) <0.001
0.001 25 (65.8%) 27 (100%) 0.001
<0.001 12 (31.6%) 25 (92.6%) `<0.001
<0.001 21 (55.3%) 26 (96.3%) <0.001
0.002 20 (52.6%) 26 (96.3%) <0.001
<0.001 1 2 <0.001
0.011 9 (23.7%) 21 (77.8%) <0.001
gestive heart failure; CKD ¼ chronic kidney disease; CLD ¼ chronic liver disease;
diastolic blood pressure; DM ¼ diabetes mellitus; HTN ¼ arterial hypertension;
respiratory rate; SBP ¼ systolic blood pressure; TP ¼ total protein; WBCs ¼ white
Table 3
Comparison between patients with ADL > 3 and those with ADL  3 with regard to
patients’ characteristics, outcome, and pneumonia scores.
Variable ADL > 3 (n ¼ 16) ADL  3 (n ¼ 49) p
Agea 63 70 0.007
Sex (male) 14 (87.5%) 25 (51%) 0.010
Comorbidities
ISHD 1 (6.2%) 15 (30.6%) 0.091
CHF 4 (25%) 9 (18.4%) 0.711
COPD 12 (75%) 18 (36.7%) 0.008
CVS 0 (0%) 8 (16.3%) 0.182
DM 2 (12.5%) 17 (34.7%) 0.121
HTN 1 (6.2%) 19 (38.8%) 0.014
Dementia 0 (0%) 8 (16.3%) 0.182
CKD 6 (37.5%) 25 (51%) 0.351
CLD 1 (6.2%) 6 (12.2%) 0.671
Clinical data
Disturbed mental state 0 (0%) 34 (69.4%) <0.001
Aspiration 0 (0%) 13 (26.5%) 0.027
Temperaturea 38 38 0.351
RRa 20 25 0.001
Pulsea 97.5 100 0.481
SBP 119.3 (12.89) 122.9 (22.08) 0.553
DBPa 80 80 0.894
Laboratory data
WBCsa 13.05 11.7 0.982
Lymphocytesa 1.45 1.2 0.645
TP 6.6 (1.04) 6.24 (0.92) 0.271
ALB 3.26 (0.73) 2.99 (0.77) 0.257
ABG
PO2 59.26 (16.57) 63.6 (18.38) 0.382
Oxygen saturationa 91.5 91 0.690
Radiological data
Bronchopneumonia 4 (25%) 25 (51%) 0.070
Pleural effusion 3 (18.8%) 12 (24.5%) 0.741
Outcome
Mortality 0 (0%) 26 (53.1%) <0.001
MV 1 (6.2%) 26 (53.1%) 0.001
LOSa 8.5 10 0.762
Pneumonia scores
CURB-65 > III (n ¼ 18) 0 (0%) 18 (36.7%) 0.003
Positive SCAP 4 (25%) 26 (53.1%) 0.050
ABG ¼ arterial blood gases; ADL ¼ activities of daily living; ALB ¼ albumin;
CHF ¼ congestive heart failure; CKD ¼ chronic kidney disease; CLD ¼ chronic liver
disease; COPD ¼ chronic obstructive pulmonary disease; CVS ¼ cerebrovascular
stroke; DBP ¼ diastolic blood pressure; DM ¼ diabetes mellitus; HTN ¼ arterial
hypertension; ISHD ¼ ischemic heart disease; LOS ¼ length of stay;
MV ¼mechanical ventilation; RR ¼ respiratory rate; SBP ¼ systolic blood pressure;
TP ¼ total protein; WBCs ¼ white blood cells.
a ManneWhitney test was used; median is expressed in the data.
Table 5
Receiver operating characteristic curve for pneumonia scores and ADL score
regarding mortality and mechanical ventilation.
Variables ADL  3 CURB-65 (III) Positive SCAP
M MV M MV M MV
AUC 0.705 0.679 0.686 0.643 0.660 0.770
Sensitivity 100% 96.3% 50% 44.44% 65.4% 77.7%
Speciﬁcity 41% 39.5% 87.2% 84.2% 66.7% 76.3%
PPV 53% 53.1% 72.2% 66.67% 56.7% 70%
NPV 100% 93.8% 72.3% 68.09% 74.3% 82.86%
p* 0.005 0.015 0.012 0.050 0.030 <0.001
95% CI 0.581
e0.829
0.550
e0.808
0.548
e0.799
0.503
e0.784
0.523
e0.797
0.650
e0.891
* Statistically signiﬁcant if p < 0.05.
CI ¼ conﬁdence interval; ADL ¼ activities of daily living; AUC ¼ area under the
curve; M ¼ mortality; MV ¼ mechanical ventilation; NPV ¼ negative predictive
value; PPV ¼ positive predictive value.
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To the best of our knowledge, this is the ﬁrst study to compare
the performance of baseline functional status using the ADL score
with two traditional severity scores for different outcomes of CAP
(MV and mortality). Our results showed that ADL scores  3 points
could signiﬁcantly predict both mortality and MV in patients with
severe CAP similar toworse CURB-65 and positive SCAP scores. This
signiﬁes the clinical importance of CAP prevention in patients with
low functional state.Table 4
Logistic regression analysis with regard to mortality end point and mechanical ventilatio
Variables Mortality
OR SE p 95% CI
ISHD 2.553 0.692 0.175 0.658e9.9
Age 1.000 0.036 0.997 0.933e1.0
Sexa 0.740 0.638 0.637 0.212e2.5
ADL score 0.383 0.355 0.007 0.191e0.7
ADL ¼ activities of daily living; CI ¼ conﬁdence interval; ISHD ¼ ischemic heart disease
a Males were the reference group.Moreover, theADL score couldhelp clinicians in identifying severe
CAP. It is important to identify high-risk patients to promptly admit
them in ICU without any delay in order to improve their clinical
outcomes. The best screening tool used should demonstrate high
sensitivity and high NPV in addition to being easily performed,
especially in the emergency department. The ADL score had the
highest sensitivity (96.3% vs. 100%) and NPV (93.8% vs. 100%) in pre-
dicting both MV and mortality, respectively, in addition to its
simplicity, as it does not depend on any laboratory assessment and
also gives earlier data for outcome prediction than other indexes,
which makes it better than other scores used for identifying severe
CAP.
The importance of ADL score in CAP is conﬁrmed by the fact that
elderly patients with reduced ADL scores have diminished cell-
mediated immunity and consequently poor CAP outcome.12 Simi-
larly, moderate aerobic exercises can decrease the upper and lower
respiratory tract infections through the favorable effect they have
on immunity function20 as a result of improved neutrophils func-
tion.21,22 Neutrophils, complement, and macrophages play an
important role in protecting the airways against microbial coloni-
zation and invasion23 of common residents in the upper airway,
which are well-known causes of CAP.24
The CURB-65 and SCAP scores have different points of strength
and weakness when used in patients in the ICU. This is supported by
Chalmers et al who found that when ICU admission is taken into
account, severity scores performed less effectively for the prediction
of CAP outcomes.25 This explains why all our cases were not cate-
gorized as severe by these indices. To minimize this weakness, we
took into account only the severe grade of CURB-65, which is 100%
sensitive in predicting death,16 while the SCAP score was a good
predictor for ICU admission and severe CAPwithworse outcomes.8,26
Another limitation of the current study is the small sample size.
However, the current predictive values of both CURB-65 and SCAP
scores are similar to other literatures. In a previous cohort, 45% of
died patients had CURB-65  3.3,27 The PPV for predict mortality
was 32%.28 The AUC for predicting in-hospital mortality was 0.65.29n.
MV
OR SE p 95% CI
03 1.349 0.707 0.672 0.337e5.391
72 0.999 0.037 0.970 0.928e1.075
84 1.245 0.648 0.735 0.350e4.433
67 0.287 0.454 0.006 0.118e0.697
; MV ¼ mechanical ventilation; OR ¼ odds ratio; SE ¼ standard error.
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either mortality, MV, or septic shock.4
The performance of CURB-65 was studied in three publica-
tions28,30,31 including 2951 patients, 264 requiring intensive treat-
ment with a pooled sensitivity of 57.2% and speciﬁcity of 77.2%. This
was similar to our study, as we found 40% of those with CURB-
65 3 had died. Sensitivity was 50%, speciﬁcity was 87.2%, PPV was
72.2%, and AUC was 0.69.
Regarding positive SCAP score, AUC was 0.72 in an externally
validated cohort for prediction of the presence of either mortality,
MV, or septic shock.4 In a large cohort study, sensitivity of positive
SCAP score was 80.7%, speciﬁcity was 47.3%, PPV was 28.8%, NPV
was 90.2%, and AUC was 0.71.20 This agreed with our results as AUC
was 0.660 and 0.770, sensitivity was 65.4% and 77.7%, speciﬁcity
was 66.7% and 76.3%, PPV was 56.7% and 70%, and NPV was 74.3%
and 82.86% for mortality and MV, respectively.
4.1. Recommendation
Themeasurement of ADL score can be an attractive substitute to
conventional indices because of its simplicity. Immediate availabil-
ity of baseline ADL score data allows it to predict CAP outcome
earlier than other indices. The ADL score represents an important
step in the future of improving risk adjustment and outcomes pre-
diction.Moreover,weemphasizemoderateexercise andvaccination
in the elderly patientswith diminishedADL, because the occurrence
of pneumonia will predict worse outcome in these patients.
5. Conclusion
In addition to its simplicity and availability, the ADL score can be
an attractive alternative to other severity scores as it has similar
accuracy to the CURB-65 and SCAP scores in prediction of mortality
and MV in patients with CAP.
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